Christoph Ackermann

2.4k total citations
59 papers, 1.5k citations indexed

About

Christoph Ackermann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Christoph Ackermann has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 28 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Christoph Ackermann's work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (8 papers). Christoph Ackermann is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (8 papers). Christoph Ackermann collaborates with scholars based in Switzerland, United Kingdom and Germany. Christoph Ackermann's co-authors include Ralph Peterli, Markus von Flüe, P Tondelli, Thomas Peters, Béatrice Kern, U Herzog, Raffaele Califano, Arthur Kavanaugh, Bettina K. Wölnerhanssen and Corinne Faivre‐Finn and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Christoph Ackermann

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Ackermann Switzerland 25 729 457 447 176 163 59 1.5k
Sunjay Jain United Kingdom 19 720 1.0× 357 0.8× 530 1.2× 109 0.6× 51 0.3× 62 1.6k
P. Kienle Germany 21 845 1.2× 359 0.8× 1.0k 2.3× 82 0.5× 90 0.6× 73 1.7k
Rajesh Bandekar United States 19 273 0.4× 377 0.8× 405 0.9× 133 0.8× 51 0.3× 48 1.3k
Frédérique Peschaud France 21 1.3k 1.8× 811 1.8× 742 1.7× 52 0.3× 122 0.7× 69 1.9k
Seong Yoon Yi South Korea 22 301 0.4× 466 1.0× 487 1.1× 62 0.4× 108 0.7× 70 1.2k
Francesco Persico Italy 18 362 0.5× 282 0.6× 140 0.3× 162 0.9× 56 0.3× 38 863
Shmuel Avital Israel 20 898 1.2× 316 0.7× 403 0.9× 91 0.5× 131 0.8× 109 1.3k
Eric Yeoh Australia 23 617 0.8× 725 1.6× 413 0.9× 395 2.2× 100 0.6× 52 1.5k
Min P. Kim United States 25 1.0k 1.4× 762 1.7× 545 1.2× 101 0.6× 26 0.2× 106 1.9k
Maria Tolia Greece 20 253 0.3× 389 0.9× 487 1.1× 133 0.8× 31 0.2× 135 1.3k

Countries citing papers authored by Christoph Ackermann

Since Specialization
Citations

This map shows the geographic impact of Christoph Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Ackermann more than expected).

Fields of papers citing papers by Christoph Ackermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Ackermann. The network helps show where Christoph Ackermann may publish in the future.

Co-authorship network of co-authors of Christoph Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Ackermann. A scholar is included among the top collaborators of Christoph Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Ackermann. Christoph Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mark, Michael, Patrizia Froesch, Sacha I. Rothschild, et al.. (2024). First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17. European Journal of Cancer. 200. 113600–113600. 3 indexed citations
3.
4.
Tsakonas, Georgios, et al.. (2023). Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis. International Journal of Cancer. 153(9). 1556–1567. 8 indexed citations
5.
Wicki, Andreas, Christoph Mamot, Khalil Zaman, et al.. (2021). 268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]. Annals of Oncology. 32. S479–S479. 4 indexed citations
6.
Ackermann, Christoph, et al.. (2021). First-line immune checkpoint inhibitors for extensive stage small-cell lung cancer: clinical developments and future directions. ESMO Open. 6(1). 100003–100003. 23 indexed citations
7.
Vansteenkiste, Johan, Els Wauters, Bart Reymen, et al.. (2019). Current status of immune checkpoint inhibition in early-stage NSCLC. Annals of Oncology. 30(8). 1244–1253. 96 indexed citations
8.
Ackermann, Christoph, Isabella Fornacon-Wood, Rebecca Tay, et al.. (2019). P1.04-44 Radiomics for Predicting Response to First-Line Anti-PD1 Therapy in Advanced NSCLC. Journal of Thoracic Oncology. 14(10). S457–S458. 1 indexed citations
9.
Ackermann, Christoph, Martin Reck, Luis Paz‐Ares, Fabrice Barlési, & Raffaele Califano. (2019). First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light. Lung Cancer. 134. 245–253. 31 indexed citations
10.
Califano, Raffaele, Fábio Gomes, Christoph Ackermann, et al.. (2019). Immune checkpoint blockade for non–small cell lung cancer: What is the role in the special populations?. European Journal of Cancer. 125. 1–11. 29 indexed citations
11.
Diem, Stefan, Mirjam Fässler, Omar Hasan Ali, et al.. (2018). Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment. Cancer Management and Research. Volume 10. 5537–5544. 2 indexed citations
12.
Güller, Ulrich, René Warschkow, Christoph Ackermann, et al.. (2017). Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Medical Weekly. 147(2930). w14473–w14473. 30 indexed citations
13.
Ackermann, Christoph & Arthur Kavanaugh. (2008). Economic Burden of Psoriatic Arthritis. PharmacoEconomics. 26(2). 121–129. 30 indexed citations
14.
Peterli, Ralph, Bettina K. Wölnerhanssen, Thomas Peters, et al.. (2007). Prospective Study of a Two-Stage Operative Concept in the Treatment of Morbid Obesity: Primary Lap-Band® Followed if Needed by Sleeve Gastrectomy with Duodenal Switch. Obesity Surgery. 17(3). 334–340. 33 indexed citations
15.
Ackermann, Christoph & Arthur Kavanaugh. (2007). Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opinion on Therapeutic Targets. 11(11). 1369–1384. 49 indexed citations
16.
Fueglistaler, Philipp, et al.. (2006). Long-Term Results After Stapled Hemorrhoidopexy: High Patient Satisfaction Despite Frequent Postoperative Symptoms. Diseases of the Colon & Rectum. 50(2). 204–212. 51 indexed citations
17.
Rosenthal, Rachel, et al.. (2006). Laparoscopic Antireflux Surgery: Long-Term Outcomes and Quality of Life. Journal of Laparoendoscopic & Advanced Surgical Techniques. 16(6). 557–561. 37 indexed citations
18.
Wölnerhanssen, Bettina K., Christoph Ackermann, Béatrice Kern, et al.. (2005). Zwölf Jahre laparoskopische Cholezystektomie: Ergebnisse einer prospektiven Studie von 4498 an einer Klinik durchgeführten Cholezystektomien. Chirurg. 76(3). 263–269. 1 indexed citations
19.
Wölnerhanssen, Bettina K., Béatrice Kern, Thomas Peters, et al.. (2005). Reduction in Slippage with 11-cm Lap-Band® and Change of Gastric Banding Technique. Obesity Surgery. 15(7). 1050–1054. 28 indexed citations
20.
Peterli, Ralph, Christoph Ackermann, & P Tondelli. (1996). Incarcerierte Zwerchfellhernie als Folge iatrogener Zwerchfelldefekte 2 Fallberichte. Der Chirurg. 67(10). 1050–1052. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunjay Jain Breakdown of academic impact, for papers by P. Kienle Breakdown of academic impact, for papers by Rajesh Bandekar Breakdown of academic impact, for papers by Frédérique Peschaud Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by Francesco Persico Breakdown of academic impact, for papers by Shmuel Avital Breakdown of academic impact, for papers by Eric Yeoh Breakdown of academic impact, for papers by Min P. Kim Breakdown of academic impact, for papers by Maria Tolia
Rankless by CCL
2026